Dr. Ali Dawood | Medicine and Dentistry | Best Researcher Award
Assist. Prof at Infectious Disease Mathematical Modelling, University of Mosul, Iraq
Professional Profiles:
🎓 Education:
- Ph.D. in Microbiology, College of Science, University of Mosul, 2015.
- M.Sc. in Biotechnology, Faculty of Bioscience and Bioengineering, University Technology Malaysia, 2011.
- B.Sc. in Microbiology, Dept. of Biology, College of Science, University of Mosul, 1989.
đź“š Training Courses:
- IC3 computer test (880), 2011.
- Extensive English course-sem.2 (2007-2008), University Technology Malaysia.
- Certificate of ITP TOEFL (score 473), August 2011.
- Certificate of Achieving Foreign Language, College of Arts, Mosul University, 1991.
đź’Ś Thankful Letters:
- Minister of Higher Education and Scientific Research.
- President of University of Mosul.
- Dean of College of Medicine, Mosul University (2006, 2008, 2012).
👨‍🏫 Professional Posts:
- Assist. Prof, College of Medicine, Uni. Of Mosul from 2021 till now. Dept. of Anatomy Rapporteur from 1/7/2021.
- Lecturer, College of Medicine, Uni. Of Mosul from 2015 till now.
- Lecturer, College of Dentistry, Uni. Of Mosul 2015-2016.
- Associate lecturer, College of Medicine, Uni. of Mosul from 2011 till 2014.
- Associate researcher, College of Medicine, Uni. Of Mosul from 2005-2009 and 1993-1994.
- Course Unit Director, College of Medicine, Uni. of Mosul from 2020 till now.
👩‍🔬 Professional Experiences:
- Teaching virology lessons for 3rd class medical students, Universities of Mosul and Nineveh 2015-2016.
- Teaching Medical Biology lessons for the first class medicine and dentistry students, University of Mosul from 2011.
- Working in Medical Laboratories.
- Teaching the scientific and laboratory lessons for the first class students in Medical Biology, Colleges of Medicine.
- Member of Iraqi Biologists Union since 1990.
Publications:
- Uneven Expression of 20 Human Papillomavirus Genes Associated with Oropharyngeal Carcinoma
- Author: A.A. Dawood
- Citations: 0
- Year: 2023
- CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), the next medical revolution against cancer | CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), la siguiente revolución médica contra el cáncer
- Author: A.A. Dawood
- Citations: 0
- Year: 2023
- The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between Mpro and antiviral drugs (nirmatrelvir and ritonavir)
- Author: A.A. Dawood
- Citations: 4
- Year: 2023
- Simulate the agarose gel of the receptor binding domain in Omicron’s spike protein inserted into the pGEM®-T Easy vector using SpeI and SacI restriction enzymes
- Author: A.A. Dawood
- Citations: 0
- Year: 2023
- Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein | DeterminaciĂłn de la afinidad de uniĂłn de la tunicamicina con las proteĂnas del SARS-CoV-2: proteinasa, proteasa, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envolvente y RBD de la glicoproteĂna Spike
- Author: A.A. Dawood
- Citations: 0
- Year: 2023
- Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants | ImplementaciĂłn de enfoques inmunoquimioinformáticos para construir mĂşltiples epĂtopos para la vacuna contra las variantes Omicron y Delta SARS-CoV-2
- Author: A.A. Dawood
- Citations: 2
- Year: 2022
- Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence
- Author: A.A. Dawood
- Citations: 14
- Year: 2022